Please login to the form below

Not currently logged in
Email:
Password:

Lundbeck promotes Andreas Eggert and Klaus Abel to senior commercial roles

Will oversee launch of new medicines and Otsuka partnership respectively

Danish pharma firm Lundbeck has promoted Andreas Eggert to senior VP for global product strategy and Klaus Abel to VP with responsibility for commercialisation of medicines from Lundbeck's partnership with Otsuka Pharmaceuticals.

Eggert, who joined Lundbeck in 2010 as VP for global product strategy, will have overall responsibility for the launches of several new medicines from Lundbeck during the next 18 months, including vortioxetine for major depression and Selincro (nalmefene) for alcohol dependence.

Prior to joining Lundbeck, Eggert spent several years at Wyeth (now part of Pfizer) where his roles included serving as director global strategic marketing and VP and global business manager.

Andreas Eggert - LundbeckKlaus Abel - Lundbeck
Andreas Eggert and Klaus Abel

Abel's responsibilities will cover the collaborative development and commercialisation of medicines Lundbeck is working on with Otsuka as part of a multi-billion dollar deal, including a once-monthly aripiprazole formulation for the treatment of schizophrenia and brexpiprazole (OPC-34712) for the treatment of schizophrenia and major depression.

Abel, who has been with Lundbeck since 2000, and was most recently executive director with commercial responsibility for several products, will report to Eggert who will in turn report directly to president and CEO Ulf Wiinberg.

23rd August 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

At Pegasus, we specialise in helping deliver healthy messages through integrated communication programmes. In fact, inspiring healthy decisions is all...

Latest intelligence

Geraldine Murphy
LEO: Patients benefit from transparency
Paving the way for openness in pharma...
Running
Biosimilars: what the future looks like
Biosimilars: what the future looks like...
compliance
Tightening medical device safety
European legislators seek to reduce patient exposure to safety risks...

Infographics